logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

David Staskin

tufts university

46H指数
264论文数
7.8K被引数
收录论文 46
发表时间
logo
Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial临床意义明确的维贝格龙在伴有良性前列腺增生症的超活跃膀胱男性中的改善效果：COURAGE III期试验的应答者分析
errUrology
IF2
err2025-12-01
err0
errOAAI
errPeters, Kenneth M.; Owens-Grillo, Janet; Thomas, Elizabeth; Staskin, David; Rovner, Eric S.; Mujais, Salim
err分享
err收藏
Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial在治疗良性前列腺增生并接受维贝格隆治疗的男性患者中，对膀胱功能及安全性的评估：来自COURAGE III期随机对照试验的结果
errNeurourology and Urodynamics
IF1.9
err2025-12-01
err0
errOAAI
errRovner, Eric S.; Owens-Grillo, Janet; Thomas, Elizabeth; Herschorn, Sender; Peters, Kenneth M.; Staskin, David; Mujais, Salim
err分享
err收藏
Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes (vol 43, 514, 2025)维贝格龙在膀胱过活动症中的应用：疗效、安全性及患者报告结局的全面综述（卷43，514，2025）
errWORLD JOURNAL OF UROLOGY
IF2.9
err2025-11-03
err0
errOAAI
errPeyronnet, Benoit; Brucker, Benjamin M.; De Nunzio, Cosimo; Gratzke, Christian; Heesakkers, John; Michel, Martin C.; Serati, Maurizio; Staskin, David; Chapple, Christopher
err分享
err收藏
Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes维贝格龙在膀胱过度活动中的应用：疗效、安全性和患者报告结局的全面综述
errWorld Journal of Urology
IF2.9
err2025-08-26
err0
errOAAI
errBenoit Peyronnet; Benjamin M. Brucker; Cosimo De Nunzio; Christian Gratzke; John Heesakkers; Martin C. Michel; Maurizio Serati; David Staskin; Christopher Chapple
err分享
err收藏
Plain Language Summary of Publication: What is the effect of the medicine vibegron in the treatment of overactive bladder in patients with and without bladder leakage?出版物简明摘要：vibegron药物在治疗有和无膀胱泄漏患者的膀胱过度活动症方面的效果如何？
errTHERAPEUTIC ADVANCES IN UROLOGY
IF3.5
err2025-01-17
err0
errOAAI
errDavid Staskin; Jeffrey Frankel; Steven G. Gregg; Janet Owens-Grillo
err分享
err收藏
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialVibegron治疗因良性前列腺增生而接受药物治疗的男性持续膀胱过度活动症的疗效和安全性: 3期随机对照COURAGE试验的结果
errJOURNAL OF UROLOGY
IF6.8
err2024-08-01
err5
errOAAI
errStaskin, David; Owens-Grillo, Janet; Thomas, Elizabeth; Rovner, Eric; Cline, Kevin; Mujais, Salim
err分享
err收藏
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
errADVANCES IN THERAPY
IF4
err2024-03-23
err0
errOAAI
errChastek, Benjamin; Carrera, Adam; Landis, Christina; Snyder, Daniel; Abedinzadeh, Laleh; Bancroft, Tim; Nesheim, Jeffrey; Kennelly, Michael; Staskin, David
err分享
err收藏
Effect of Pharmacotherapy for Overactive Bladder on the Incidence of and Factors Related to Urinary Tract Infection: A Systematic Review and Meta-analysis. Letter.
errJOURNAL OF UROLOGY
IF6.8
err2023-07-01
err0
PREAI
errUrkmez, Ahmet; Staskin, David
err分享
err收藏
Study Designs for Evaluation of Combination Treatment: Focus on Individual Patient Benefit联合治疗评估的研究设计: 关注个体患者的益处
errBIOMEDICINES
IF3.9
err2022-01-26
err6
errOAAI
errMichel, Martin C.; Staskin, David
err分享
err收藏
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR
errADVANCES IN THERAPY
IF4
err2021-12-18
err8
errOAAI
errFrankel, Jeffrey; Staskin, David; Varano, Susann; Kennelly, Michael; Newman, Diane K.; Rosenberg, Matt T.; Jankowich, Rachael A.; Shortino, Denise; Mudd, Paul N., Jr.; Girman, Cynthia J.
err分享
err收藏
Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR)
errJOURNAL OF UROLOGY
IF6.8
err2021-05-01
err29
errOAAI
errStaskin, David; Frankel, Jeffrey; Varano, Susann; Shortino, Denise; Jankowich, Rachael; Mudd, Paul N., Jr.
err分享
err收藏
Efficacy and Safety of Once-Daily Vibegron for Treatment of Overactive Bladder in Patients Aged ≥65 and ≥75 Years: Subpopulation Analysis from the EMPOWUR Randomized, International, Phase III Study
errDRUGS & AGING
IF3.8
err2021-01-20
err22
errOAAI
errVarano, Susann; Staskin, David; Frankel, Jeffrey; Shortino, Denise; Jankowich, Rachael; Mudd, Paul N.
err分享
err收藏
International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR
errJOURNAL OF UROLOGY
IF6.8
err2020-08-01
err81
PREAI
errStaskin, David; Frankel, Jeffrey; Varano, Susann; Shortino, Denise; Jankowich, Rachael; Mudd, Paul N., Jr.
err分享
err收藏
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet
errDRUGS & AGING
IF3.8
err2020-07-28
err15
errOAAI
errHerschorn, Sender; Staskin, David; Schermer, Carol R.; Kristy, Rita M.; Wagg, Adrian
err分享
err收藏
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)在接受坦索罗辛治疗潜在良性前列腺增生的患有膀胱过度活动症的男性中，mirabegon与安慰剂附加疗法的疗效和安全性: 一项随机，4期研究 (PLUS)
errJOURNAL OF UROLOGY
IF6.8
err2020-06-01
err35
PREAI
errKaplan, Steven A.; Herschorn, Sender; McVary, Kevin T.; Staskin, David; Chapple, Christopher; Foley, Steve; Santos, Javier Cambronero; Kristy, Rita M.; Choudhury, Nurul; Hairston, John; Schermer, Carol R.
err分享
err收藏
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)
errBMC GERIATRICS
IF3.8
err2020-03-18
err50
errOAAI
errGriebling, Tomas L.; Campbell, Noll L.; Mangel, Jeffrey; Staskin, David; Herschorn, Sender; Elsouda, Dina; Schermer, Carol R.
err分享
err收藏
Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)
errEUROPEAN UROLOGY
IF25.2
err2020-02-01
err60
errOAAI
errWagg, Adrian; Staskin, David; Engel, Eli; Herschorn, Sender; Kristy, Rita M.; Schermer, Carol R.
err分享
err收藏
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or PlaceboMirab的安全性和有效性: 对接受mirab，抗毒蕈碱或安慰剂的膀胱过度活动症患者的大型综合临床试验数据库的分析
errEUROPEAN UROLOGY
IF25.2
err2020-01-01
err50
errOAAI
errChapple, Christopher R.; Cruz, Francisco; Cardozo, Linda; Staskin, David; Herschorn, Sender; Choudhury, Nurul; Stoelzel, Matthias; Heesakkers, John; Siddiqui, Emad
err分享
err收藏
Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment联合药物治疗膀胱过度活动症患者的疗效和安全性: 快速证据评估
errEUROPEAN UROLOGY
IF25.2
err2019-12-01
err21
PREAI
errGratzke, Christian; Chapple, Christopher; Mueller, Elizabeth R.; Robinson, Dudley; Rolland, Catherine; Staskin, David; Stoelzel, Matthias; van Maanen, Rob; Siddiqui, Emad
err分享
err收藏
Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence
errJOURNAL OF UROLOGY
IF6.8
err2019-05-01
err38
PREAI
errMacDiarmid, Scott; Staskin, David R.; Lucente, Vincent; Kaaki, Bilal; English, Sharon; Gilling, Peter; Meffan, Patrick; Clark, Matthew; Sand, Peter K.; Sen, Subhro K.; Rovner, Eric
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
C
Claus G. Roehrborn
H 指数: 111 · 论文数: 951
C
Christopher R. Chapple
H 指数: 102 · 论文数: 1.4K
P
Paul Abrams
H 指数: 97 · 论文数: 652
M
Michael B. Chancellor
H 指数: 91 · 论文数: 1.0K
R
Roger R. Dmochowski
H 指数: 85 · 论文数: 1.0K
查看更多